{"componentChunkName":"component---src-templates-chapter-level-2-chapter-level-2-tsx","path":"/topics/sinusitis/how-up-to-date-is-this-topic/changes/","result":{"pageContext":{"chapter":{"id":"36290f8d-5730-5655-8fa4-0d3f584a2980","slug":"changes","fullItemName":"Changes","depth":2,"htmlHeader":"<!-- begin field 815887a9-eb50-487b-97f6-fb041eb6fa64 --><h2>Changes</h2><!-- end field 815887a9-eb50-487b-97f6-fb041eb6fa64 -->","summary":null,"htmlStringContent":"<!-- begin item c749aec0-6674-473d-9e69-3901407f7f6d --><!-- begin field e09d1e72-a735-45f6-b085-1f8fa43373d0 --><p><strong>May to June 2018 </strong>— reviewed. A literature search was conducted in May 2018 to identify evidence-based guidelines, UK policy, systematic reviews, and key RCTs published since the last revision of this topic. Sections have been added on prevalence, complications, and antibiotic choice for acute sinusitis, and a prescribing information section is now available. There have been minor changes to the sections on diagnosis of acute and chronic sinusitis. The scenarios on acute and chronic sinusitis have undergone minor restructuring and have been updated with more detailed information on referral, and links to sources of patient information.</p><!-- end field e09d1e72-a735-45f6-b085-1f8fa43373d0 --><!-- end item c749aec0-6674-473d-9e69-3901407f7f6d -->","topic":{"id":"6d2333af-675d-5bf3-8f7d-21404b5f0aa9","topicId":"251eec02-9620-4893-97bb-7a4e69e81da3","topicName":"Sinusitis","slug":"sinusitis","lastRevised":"Last revised in June 2018","chapters":[{"id":"2e4afda1-e9d5-5296-a027-01f4617ab6d0","fullItemName":"Summary","slug":"summary","subChapters":[]},{"id":"405b3d6d-e395-5fea-bc5e-02ddf80a8bd2","fullItemName":"Have I got the right topic?","slug":"have-i-got-the-right-topic","subChapters":[]},{"id":"22d307e8-3756-562c-b49a-55d20a9d0c5d","fullItemName":"How up-to-date is this topic?","slug":"how-up-to-date-is-this-topic","subChapters":[{"id":"36290f8d-5730-5655-8fa4-0d3f584a2980","slug":"changes","fullItemName":"Changes"},{"id":"b0ba5cc8-0ed6-52d6-86c5-12833f47d8d3","slug":"update","fullItemName":"Update"}]},{"id":"f730377b-2158-527d-b9a1-e99c0653afd0","fullItemName":"Goals and outcome measures","slug":"goals-outcome-measures","subChapters":[{"id":"5f96218a-0038-5b66-8c21-7db2d19f37b7","slug":"goals","fullItemName":"Goals"},{"id":"f4318fc5-fa1f-52cc-964f-2eeb9d4f7a27","slug":"outcome-measures","fullItemName":"Outcome measures"},{"id":"5a355772-1fc0-5033-929c-388a6956d7f5","slug":"audit-criteria","fullItemName":"Audit criteria"},{"id":"41d933ba-5f60-5f51-9a18-8d60f08747d9","slug":"qof-indicators","fullItemName":"QOF indicators"},{"id":"de2c52a0-2248-5977-a8e4-e495835a4f71","slug":"qipp-options-for-local-implementation","fullItemName":"QIPP - Options for local implementation"},{"id":"87fd2967-db43-5938-a83c-4761cd508da1","slug":"nice-quality-standards","fullItemName":"NICE quality standards"}]},{"id":"6b9273f7-5c2c-5994-a3d4-8617be04677e","fullItemName":"Background information","slug":"background-information","subChapters":[{"id":"62fda2cc-020c-5dda-8886-be553f1b04bc","slug":"definition","fullItemName":"Definition"},{"id":"d0ca7ab5-8889-52dd-8ac6-bcf949adf403","slug":"causes","fullItemName":"Causes"},{"id":"6c331f3e-5cee-537d-9ff6-41dba5324ae1","slug":"prevalence","fullItemName":"Prevalence"},{"id":"2b91bcbf-5ce3-5cdb-bb8d-03f4297a60fc","slug":"complications","fullItemName":"Complications"}]},{"id":"17787dc5-901a-5bd4-93f1-b3bd7830f0a8","fullItemName":"Diagnosis","slug":"diagnosis","subChapters":[{"id":"a3d013cf-b195-59ed-ac16-d0dc956a2637","slug":"diagnosis-acute-sinusitis","fullItemName":"Diagnosis - acute sinusitis"},{"id":"35be5a2e-61f3-5478-b238-c91020678ab0","slug":"diagnosis-chronic-sinusitis","fullItemName":"Diagnosis - chronic sinusitis"},{"id":"3ec7ffd9-5556-5eb7-9e51-14b4e1403c11","slug":"differential-diagnosis","fullItemName":"Differential diagnosis"}]},{"id":"a5e0292f-f277-5859-bf17-fe0b4557eae3","fullItemName":"Management","slug":"management","subChapters":[{"id":"851420e1-952f-58e9-bb2d-b69ed5134584","slug":"acute-sinusitis","fullItemName":"Scenario: Acute sinusitis"},{"id":"fe33ee40-93d8-59ba-b62a-2f9ccc74cc63","slug":"chronic-sinusitis","fullItemName":"Scenario: Chronic sinusitis"}]},{"id":"ccbcf182-fe04-59e6-abdc-75557dc3c700","fullItemName":"Prescribing information","slug":"prescribing-information","subChapters":[{"id":"bc9974c3-e759-5746-8c96-b4538af16946","slug":"analgesia","fullItemName":"Analgesia"},{"id":"b7e24d48-87af-5f2c-9097-f4e3b1de894d","slug":"nasal-corticosteroids","fullItemName":"Nasal corticosteroids"},{"id":"5f63c8f8-0eaa-5fe0-b473-2d5e3aef00d1","slug":"clarithromycin","fullItemName":"Clarithromycin"},{"id":"0d802baf-8d25-5d8a-9c6d-b2a448983e4a","slug":"co-amoxiclav","fullItemName":"Co-amoxiclav"},{"id":"e874a37b-5cc8-58c8-9335-ac01e3b17271","slug":"doxycycline","fullItemName":"Doxycycline"},{"id":"bb4fef09-b30c-5637-ae85-ba203f26acd9","slug":"phenoxymethylpenicillin","fullItemName":"Phenoxymethylpenicillin"}]},{"id":"827f1e92-8727-5460-b9ae-00929701cc77","fullItemName":"Supporting evidence","slug":"supporting-evidence","subChapters":[]},{"id":"4dbc93c2-6562-533b-8dd9-0891fc35822e","fullItemName":"How this topic was developed","slug":"how-this-topic-was-developed","subChapters":[{"id":"8b0f7242-5fbb-5eb4-8b1a-13af5d4383df","slug":"search-strategy","fullItemName":"Search strategy"},{"id":"4a3d9d72-ed21-52d6-ba45-abcfb27ec6b4","slug":"stakeholder-engagement","fullItemName":"Stakeholder engagement"},{"id":"1b69a1e4-ec7f-5483-873c-2bb4bfb1345c","slug":"evidence-exclusion-criteria","fullItemName":"Evidence exclusion criteria"},{"id":"f04034ff-dd83-5bf5-83de-77fe9877df85","slug":"organizational-behavioural-financial-barriers","fullItemName":"Organizational, behavioural and financial barriers"},{"id":"f54f59b3-2893-5e4b-8dd2-3bee521cb237","slug":"declarations-of-interest","fullItemName":"Declarations of interest"}]},{"id":"164a0943-7f01-50bd-8c8f-a3695b72b662","fullItemName":"References","slug":"references","subChapters":[]}]},"parentChapter":{"id":"22d307e8-3756-562c-b49a-55d20a9d0c5d","slug":"how-up-to-date-is-this-topic","fullItemName":"How up-to-date is this topic?"},"subChapters":[{"id":"452c1ef7-a7f6-5d63-a4cf-2ca9799714c1","slug":"previous-changes","fullItemName":"Previous changes","depth":3,"htmlHeader":"<!-- begin field 67f7c094-1063-4e85-9c62-0af22072c931 --><h3>Previous changes</h3><!-- end field 67f7c094-1063-4e85-9c62-0af22072c931 -->","summary":null,"htmlStringContent":"<!-- begin item 4204f9fa-eab3-4fde-9024-df69aa6e0f4e --><!-- begin field f343fd92-63bc-4101-8814-70b61054a4ac --><p><strong>October 2017 </strong>— reviewed. Updated as a result of the publication of the NICE guideline <em>Sinusitis (acute): antimicrobial prescribing</em>. Revised recommendations on prescribing antibiotics, intranasal corticosteroids and self-management. </p><p><strong>October 2013 </strong>— reviewed. A literature search was conducted in June 2013 to identify evidence-based guidelines, UK policy, systematic reviews, and key RCTs published since the last revision of this topic. The diagnostic criteria for both acute and chronic sinusitis in children have been updated in line with recommendations from the European Position Statement 2012 group (EPOS 2012), published in the European guidance: <em>European position paper on rhinosinusitis and nasal polyps</em>. Recommendations have been added about when to suspect acute bacterial sinusitis, and recommendations about when to prescribe antibiotics have changed accordingly. Recommendations have been added about when to consider prescribing intranasal corticosteroids for the symptomatic treatment of acute sinusitis.</p><p><strong>February 2013 </strong>— minor update. The 2013 QIPP options for local implementation have been added to this topic.</p><p><strong>October 2012 </strong>— minor update. The 2012 QIPP options for local implementation have been added to this topic.</p><p><strong>September 2012 </strong>— minor update. Ephedrine 0.5% nasal drops are no longer licensed for use in children younger than 12 years of age. Prescriptions have been updated.</p><p><strong>July 2011 </strong>— minor update. More exact paracetamol dosing for children has been introduced by the Medicines and Healthcare products Regulatory Agency. Prescriptions have been updated to reflect the revised dosing. Issued in July 2011.</p><p><strong>May 2011 </strong>— minor update. The 2010/2011 QIPP options for local implementation have been added to this topic. Issued in June 2011.</p><p><strong>September 2010 </strong>— minor update. The likely causative pathogens have been added to the <em>Causes</em> section, and the rationale for using high-dose amoxicillin (if an antibiotic is indicated) has been added to the topic. Issued in September 2010.</p><p><strong>August 2009 </strong>— minor update. Xylometazoline 0.05% nasal drops (Otrivine Child Nasal Drops<sup>®</sup>) are no longer licensed for use in children between 2 and 5 years of age. They can be prescribed for children who are 6 years of age and over. Issued in August 2009.</p><p><strong>October 2008 to March 2009 </strong>— converted from CKS guidance to CKS topic structure. The evidence-base has been reviewed in detail, and recommendations are more clearly justified and transparently linked to the supporting evidence. Recommendations for the prescribing of antibiotics for acute sinusitis are now based on the clinical guideline <em>Respiratory tract infections — antibiotic prescribing, </em>published by the National Institute for Health and Care Excellence.</p><p><strong>December 2007 </strong>— updated. Macrolide options changed to erythromycin or clarithromycin in line with advice from the Health Protection Agency. Issued in January 2008.</p><p><strong>October 2006 </strong>— minor update. Analgesia prescriptions updated because new doses of ibuprofen for children are recommended by the British National Formulary. Issued in October 2006.</p><p><strong>July to September 2005 </strong>— reviewed. Validated in December 2005 and issued in February 2006.</p><p><strong>March 2004 </strong>— updated with additional information for nurse prescribers. Issued in March 2004.</p><p><strong>March 2002 </strong>— rewritten and renamed <em>Sinusitis</em>. Validated in June 2002 and issued in July 2002.</p><p><strong>August 1998 </strong>— written, replacing guidance on <em>Acute sinusitis </em>and <em>Chronic sinusitis</em>. Validated in November 1998 and issued in December 1998.</p><!-- end field f343fd92-63bc-4101-8814-70b61054a4ac --><!-- end item 4204f9fa-eab3-4fde-9024-df69aa6e0f4e -->","subChapters":[]}]}}},"staticQueryHashes":["3666801979"]}